Tag: danicopan

Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…

(CercleFinance.com) – AstraZeneca announces positive results from a pivotal phase III trial showing that danicopan, in addition to standard C5 inhibitor treatment, Ultomiris (ravulizumab) or Soliris (eculizumab) continued to demonstrate…